miRview™ squamous is a cutting-edge molecular diagnostic test that uses microRNA to accurately differentiate squamous from nonsquamous NSCLC, helping you make informed decisions. Unlike current methods, miRview™ squamous provides a differential diagnosis with
- Fast, standardized, and objective classification
- The highest level of accuracy demonstrated by 2 studies
- 100% sensitivity and specificity in a recent blinded, post-approval
validation study1
- In a study which determined the test's specification, the sensitivity and specificity were 97% and 91% respectively2
- Simple interpretation
- Routine sample preparation
- Bishop JA, Benjamin H, Cholakh H, Chajat A, Clark DP, Westra WH. Accurate classification of non–small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res. 2010;16(2):610-619.
- Lebanony D, Benjamin H, Gilad S, et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol. 2009;27(12):2030-2037.
